Amylyx Pharmaceuticals, Inc. (AMLX)
17.12
+0.20
(+1.18%)
USD |
NASDAQ |
Apr 15, 16:00
17.11
-0.01
(-0.06%)
After-Hours: 20:00
Amylyx Pharmaceuticals Research and Development Expense (Annual) : 89.88M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Disc Medicine, Inc. | 170.36M |
| Cytokinetics, Inc. | 405.90M |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| MediciNova, Inc. | 7.135M |
| Scholar Rock Holding Corp. | 206.78M |